| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $0 ) |
| | 2026 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | T03OH012806 | Translating the Fisherman First Aid and Safety Training (FFAST) for Commercial Fishermen in the Southeastern United States | 02 | 1 | CDC | 11/13/2025 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $65,751,269 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI180075 | Treatment outcome requirements for disease prevention in Chagas disease | 000 | 2 | NIH | 7/14/2025 | $637,608 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM111939 | Structure and Function in alpha-Dystroglycan Glycosylation | 001 | 11 | NIH | 8/6/2025 | $37,769 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21NS135412 | Characterizing and treating peripheral nervous system dysfunction in Sanfilippo Syndrome | 000 | 1 | NIH | 1/27/2025 | $226,500 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL172496 | Nitric Oxide Functionalized Antibiotics to Combat Infections and Thrombosis for Extracorporeal Life Support | 001 | 2 | NIH | 8/27/2025 | $48,930 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL172496 | Nitric Oxide Functionalized Antibiotics to Combat Infections and Thrombosis for Extracorporeal Life Support | 000 | 2 | NIH | 1/28/2025 | $440,366 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM154846 | Heparan sulfate co-polymerase function and defects in disease | 000 | 2 | NIH | 7/29/2025 | $332,957 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM150794 | Understanding inter-organellar communication in apicomplexan parasites | 000 | 3 | NIH | 7/2/2025 | $377,500 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01NS131659 | Developmental Programs as Vulnerabilities in H3.3G34-Mutant High-Grade Glioma | 001 | 2 | NIH | 8/18/2025 | $352,345 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM153268 | Epigenomic consequences of breakage-fusion-bridge cycling | 001 | 2 | NIH | 5/26/2025 | $368,444 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL173931 | Metabolic control of human endothelial development via the COUP-TF/1-deoxysphingosine axis | 001 | 2 | NIH | 7/1/2025 | $56,810 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL173931 | Metabolic control of human endothelial development via the COUP-TF/1-deoxysphingosine axis | 000 | 2 | NIH | 3/28/2025 | $511,305 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DA055630 | Early Adversity and Drug Use Vulnerability Among Low Income Rural Children: Testing a Neuro-ecological Model of Resilience | 002 | 3 | NIH | 4/9/2025 | $68,369 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DA055630 | Early Adversity and Drug Use Vulnerability Among Low Income Rural Children: Testing a Neuro-ecological Model of Resilience | 001 | 3 | NIH | 1/22/2025 | $54,644 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DA055630 | Early Adversity and Drug Use Vulnerability Among Low Income Rural Children: Testing a Neuro-ecological Model of Resilience | 000 | 3 | NIH | 1/17/2025 | $615,311 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21LM014569 | AI-MedWise: Developing and validating an artificial intelligence solution for effective video-based monitoring of medication adherence | 001 | 2 | NIH | 7/31/2025 | $169,875 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R33MH121560 | Cognitive Training for Emotion Regulation in Psychotic Disorders | 000 | 4 | NIH | 8/5/2025 | $549,411 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21HD112848 | Uterine epithelial ERα regulates preimplantation uterine immunity and sperm fitness | 000 | 2 | NIH | 5/30/2025 | $188,750 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI176776 | Synthesis and transport of outer membrane components across the Gram-negative cell envelope | 000 | 3 | NIH | 12/23/2024 | $640,850 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21EY034691 | Atypical Pathological Signaling as a Target to Regulate Retinal Vasculopathies | 000 | 2 | NIH | 8/4/2025 | $182,713 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL163256 | Effects of Early Life Exposure to Household Air Pollution on DNA Methylation and Respiratory Disease in Guatemalan Children from the Household Air Pollution Intervention Network (HAPIN) Trial | 001 | 3 | NIH | 9/10/2025 | $169,619 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL163256 | Effects of Early Life Exposure to Household Air Pollution on DNA Methylation and Respiratory Disease in Guatemalan Children from the Household Air Pollution Intervention Network (HAPIN) Trial | 000 | 3 | NIH | 8/28/2025 | $424,320 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31AI181461 | Understanding Plasmodium falciparum's multidrug resistance protein through the characterization of a novel antimalarial class. | 001 | 2 | NIH | 8/1/2025 | $564 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31AI181461 | Understanding Plasmodium falciparum's multidrug resistance protein through the characterization of a novel antimalarial class. | 000 | 2 | NIH | 5/7/2025 | $48,974 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI173144 | Impacts of host lipid composition on antimicrobial susceptibilities of Staphylococcus aureus | 000 | 3 | NIH | 11/4/2024 | $471,568 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | K01AR082421 | Steps Towards OA Prevention | 000 | 3 | NIH | 7/10/2025 | $121,473 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM150916 | Molecular mechanisms of physical interactions between bacteria and their surroundings | 000 | 3 | NIH | 8/7/2025 | $368,444 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI158743 | Synthetic multi-component influenza vaccines to elicit broad immunity | 000 | 2 | NIH | 11/1/2024 | $660,492 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI180871 | Gene regulation in Cryptosporidium | 000 | 2 | NIH | 4/30/2025 | $184,314 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI185250 | Roles of C. albicans white-opaque regulators in biofilm and virulence | 000 | 2 | NIH | 5/13/2025 | $195,312 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM158187 | Molecular mechanism of MFS and MOP lipid transporters in cell wall biosynthesis. | 000 | 1 | NIH | 5/27/2025 | $394,068 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01NS114567 | Genipin’s ECM Crosslinking Action as an Agent to Prevent Neurodegeneration in Familial Dysautonomia | 002 | 6 | NIH | 6/16/2025 | $569,730 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01NS114567 | Genipin’s ECM Crosslinking Action as an Agent to Prevent Neurodegeneration in Familial Dysautonomia | 000 | 5 | NIH | 11/27/2024 | $339,750 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | K01HD110683 | State economic support policies on the prevention of child abuse and neglect during and post the COVID-19 pandemic: Bridging evidence with policy implementation | 000 | 4 | NIH | 8/5/2025 | $132,381 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI175925 | Development of ganglioside specific IgGs for the treatment of Guillian-Barré Syndrome | 000 | 2 | NIH | 12/6/2024 | $182,243 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01NS114567 | Genipin’s ECM Crosslinking Action as an Agent to Prevent Neurodegeneration in Familial Dysautonomia | 001 | 5 | NIH | 6/13/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01NS114567 | Genipin’s ECM Crosslinking Action as an Agent to Prevent Neurodegeneration in Familial Dysautonomia | 004 | 6 | NIH | 9/4/2025 | -$199,107 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01NS114567 | Genipin’s ECM Crosslinking Action as an Agent to Prevent Neurodegeneration in Familial Dysautonomia | 003 | 5 | NIH | 8/28/2025 | -$199,107 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AA026362 | The Neurokinin-1 Receptor as a Mediator of Alcoholism and Depression Comorbidity | 002 | 7 | NIH | 8/26/2025 | $340,623 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AG093018 | Navigating the Transition to Middle Age in the Strong African American Healthy Adults Project (SHAPE) | 000 | 1 | NIH | 8/27/2025 | $660,434 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DK138306 | Advancing Targeted Therapies for Cushing's Disease Using Pituitary Neuroendocrine Tumor Organoids | 000 | 1 | NIH | 9/11/2025 | $3,162,826 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM163243 | DMS/NIGMS1: Unravel the connection between deformability and motility of eukaryotic cell through a | 000 | 1 | NIH | 8/8/2025 | $189,854 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AG077386 | Stress, Weathering, and Blood-Based Biomarkers of Alzheimer’s Disease | 000 | 2 | NIH | 8/7/2025 | $828,609 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | 90ZB0040 | Elevating Couple Relationships across Georgia is a campus-community initiative to strengthen families by enhancing the relationship skills and financial capability for at least 1,275 adult couples. | 00 | 1 | ACF | 9/26/2025 | $1,238,000 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI140719 | Cryptococcal vaccine development based on strong immunity induced by morphological strains | 002 | 7 | NIH | 4/30/2025 | $577,493 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI193123 | Memory Regulatory T cells in Recurring Malaria | 000 | 1 | NIH | 7/23/2025 | $650,020 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI193187 | Characterizing a feedback signal balancing lipopolysaccharide and glycerophospholipid synthesis in Gram negative bacteria | 000 | 1 | NIH | 8/21/2025 | $415,250 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM158412 | Merging bacteriophage biology with microbial glycobiology | 000 | 1 | NIH | 7/4/2025 | $377,500 |
|
